Literature DB >> 20452342

Inhibition of ATP-induced macrophage death by emodin via antagonizing P2X7 receptor.

Lijun Liu1, Jie Zou, Xing Liu, Lin-Hua Jiang, Junying Li.   

Abstract

Emodin (1,3,8-trihydroxy-6-methylanthraquinone), an anthraquinone derivative from Rheum officinale Baill, exhibits anti-inflammatory and immunosuppressive activities, however, the underlying mechanisms are not fully understood. This study examined the effects of emodin on ATP-evoked responses in rat peritoneal macrophages and in human embryonic kidney 293 cells (HEK293) heterologously expressing the cloned rat P2X7 receptor. Emodin reduced macrophage death induced by millimolar ATP in a concentration-dependent manner with the half of maximal inhibition values (IC50) of 0.2 microM. It also strongly inhibited ATP-induced dye uptake or pore formation, a hallmark property associated with P2X7 receptor activation, and 2',3'-O-(benzoyl-4-benzoyl)-ATP (BzATP) induced increases in intracellular Ca2+ concentrations in macrophages with an IC50 of 0.5 microM. Furthermore, emodin significantly suppressed BzATP-evoked currents in P2X7 receptor expressing HEK293 cells with an IC50 of 3.4 microM. Taken together, these results provide compelling evidence for a novel action of emodin as a P2X7 receptor antagonist, which may underlie its anti-inflammatory and immunosuppressive activities. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452342     DOI: 10.1016/j.ejphar.2010.04.036

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

1.  New intriguing roles of ATP and its receptors in promoting tumor metastasis : presented by Maria P. Abbracchio.

Authors:  Elena Adinolfi
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

2.  Emodin reduces tumor burden by diminishing M2-like macrophages in colorectal cancer.

Authors:  Alexander T Sougiannis; Brandon VanderVeen; Ioulia Chatzistamou; Jason L Kubinak; Mitzi Nagarkatti; Daping Fan; E Angela Murphy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-01-12       Impact factor: 4.052

Review 3.  Pyroptosis in acute pancreatitis and its therapeutic regulation.

Authors:  Abdullah Al Mamun; Suzia Aktar Suchi; Md Abdul Aziz; Muhammad Zaeem; Fahad Munir; Yanqing Wu; Jian Xiao
Journal:  Apoptosis       Date:  2022-06-10       Impact factor: 5.561

Review 4.  Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment.

Authors:  Xiaopeng Ai; Xing Dong; Ying Guo; Peng Yang; Ya Hou; Jinrong Bai; Sanyin Zhang; Xiaobo Wang
Journal:  Purinergic Signal       Date:  2021-03-22       Impact factor: 3.765

Review 5.  P2X7 receptor: a critical regulator and potential target for breast cancer.

Authors:  Xiaodi Zhu; Qianqian Li; Wei Song; Xiaoxiang Peng; Ronglan Zhao
Journal:  J Mol Med (Berl)       Date:  2021-01-23       Impact factor: 4.599

6.  Rhein antagonizes P2X7 receptor in rat peritoneal macrophages.

Authors:  Fen Hu; Fulin Xing; Ge Zhu; Guangxue Xu; Cunbo Li; Junle Qu; Imshik Lee; Leiting Pan
Journal:  Sci Rep       Date:  2015-09-10       Impact factor: 4.379

7.  Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists.

Authors:  Emily A Caseley; Stephen P Muench; Colin W Fishwick; Lin-Hua Jiang
Journal:  Biochem Pharmacol       Date:  2016-07-29       Impact factor: 5.858

Review 8.  Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer.

Authors:  Matthew Drill; Nigel C Jones; Martin Hunn; Terence J O'Brien; Mastura Monif
Journal:  Purinergic Signal       Date:  2021-03-17       Impact factor: 3.765

9.  Insights into the Molecular Mechanisms Underlying Mammalian P2X7 Receptor Functions and Contributions in Diseases, Revealed by Structural Modeling and Single Nucleotide Polymorphisms.

Authors:  Lin-Hua Jiang; Jocelyn M Baldwin; Sebastien Roger; Stephen A Baldwin
Journal:  Front Pharmacol       Date:  2013-05-07       Impact factor: 5.810

10.  Natural Products as a Source for New Anti-Inflammatory and Analgesic Compounds through the Inhibition of Purinergic P2X Receptors.

Authors:  Rômulo José Soares-Bezerra; Andrea Surrage Calheiros; Natiele Carla da Silva Ferreira; Valber da Silva Frutuoso; Luiz Anastacio Alves
Journal:  Pharmaceuticals (Basel)       Date:  2013-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.